These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33990383)

  • 1. Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool.
    Curtius K; Kabir M; Al Bakir I; Choi CHR; Hartono JL; Johnson M; East JE; ; Lindsay JO; Vega R; Thomas-Gibson S; Warusavitarne J; Wilson A; Graham TA; Hart A
    Gut; 2022 Apr; 71(4):705-715. PubMed ID: 33990383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.
    Fumery M; Dulai PS; Gupta S; Prokop LJ; Ramamoorthy S; Sandborn WJ; Singh S
    Clin Gastroenterol Hepatol; 2017 May; 15(5):665-674.e5. PubMed ID: 27916678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer.
    Choi CH; Ignjatovic-Wilson A; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Rutter MD; Graham TA; Hart AL
    Am J Gastroenterol; 2015 Oct; 110(10):1461-71; quiz 1472. PubMed ID: 26416190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
    De Jong ME; Van Tilburg SB; Nissen LHC; Kievit W; Nagtegaal ID; Horjus CS; Römkens TEH; Drenth JPH; Hoentjen F; Derikx LAAP
    J Crohns Colitis; 2019 Dec; 13(12):1485-1491. PubMed ID: 31175827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location.
    Goldstone R; Itzkowitz S; Harpaz N; Ullman T
    Gastrointest Endosc; 2011 Nov; 74(5):1087-93. PubMed ID: 21907984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
    Eaton JE; Smyrk TC; Imam M; Pardi DS; Loftus EV; Owens VL; Talwalkar JA
    Aliment Pharmacol Ther; 2013 Oct; 38(8):977-87. PubMed ID: 24033551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
    Pekow JR; Hetzel JT; Rothe JA; Hanauer SB; Turner JR; Hart J; Noffsinger A; Huo D; Rubin DT
    Inflamm Bowel Dis; 2010 Aug; 16(8):1352-6. PubMed ID: 20027656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing individualized management of patients with ulcerative colitis: Identification of risk factors predicting ulcerative colitis-associated neoplasia.
    Jiang W; Lu M; Zhang L; Xu C; Wang R; Xu Y; Tang W; Zhang H
    Medicine (Baltimore); 2023 Aug; 102(32):e34729. PubMed ID: 37565846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.
    Gupta RB; Harpaz N; Itzkowitz S; Hossain S; Matula S; Kornbluth A; Bodian C; Ullman T
    Gastroenterology; 2007 Oct; 133(4):1099-105; quiz 1340-1. PubMed ID: 17919486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.
    Thomas T; Abrams KA; Robinson RJ; Mayberry JF
    Aliment Pharmacol Ther; 2007 Mar; 25(6):657-68. PubMed ID: 17311598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey.
    Ünal NG; Özütemiz Ö; Tekin F; Turan İ; Osmanoğlu N
    Turk J Gastroenterol; 2019 Feb; 30(2):139-147. PubMed ID: 30460897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
    Garrity-Park MM; Loftus EV; Bryant SC; Smyrk TC
    Inflamm Bowel Dis; 2016 Jul; 22(7):1568-74. PubMed ID: 27135485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines.
    Zisman TL; Bronner MP; Rulyak S; Kowdley KV; Saunders M; Lee SD; Ko C; Kimmey MB; Stevens A; Maurer J; Brentnall TA
    Inflamm Bowel Dis; 2012 Dec; 18(12):2240-6. PubMed ID: 22508402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic resection is feasible for high-grade dysplasia in patients with ulcerative colitis.
    Nishio M; Hirasawa K; Chiba S; Ozeki Y; Sawada A; Ikeda R; Fukuchi T; Kobayashi R; Sato C; Inayama Y; Kunisaki R; Maeda S
    Scand J Gastroenterol; 2023 Jan; 58(1):101-106. PubMed ID: 36200368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of high-grade dysplasia and colorectal cancer in inflammatory bowel disease patients with recurrent low-grade dysplasia.
    de Jong ME; Kanne H; Nissen LHC; Drenth JPH; Derikx LAAP; Hoentjen F
    Gastrointest Endosc; 2020 Jun; 91(6):1334-1342.e1. PubMed ID: 31923409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with Endoscopically Visible Polypoid Adenomatous Lesions Within the Extent of Ulcerative Colitis Have an Increased Risk of Colorectal Cancer Despite Endoscopic Resection.
    Subramanian V; Chatu S; Echterdiek F; Banerjee A; Finlayson C; Pollok RCG
    Dig Dis Sci; 2016 Oct; 61(10):3031-3036. PubMed ID: 27405991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.